Nisa Investment Advisors LLC trimmed its stake in shares of CIGNA Co. (NYSE:CI) by 0.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 110,907 shares of the health services provider’s stock after selling 1,050 shares during the quarter. Nisa Investment Advisors LLC’s holdings in CIGNA were worth $22,524,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of CI. Investec Asset Management LTD grew its holdings in CIGNA by 35.4% during the third quarter. Investec Asset Management LTD now owns 1,849,598 shares of the health services provider’s stock worth $345,764,000 after acquiring an additional 483,904 shares during the period. FMR LLC boosted its position in CIGNA by 6.7% during the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after purchasing an additional 432,978 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in CIGNA by 4,082.8% during the second quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock worth $73,355,000 after purchasing an additional 427,754 shares in the last quarter. Vanguard Group Inc. boosted its position in CIGNA by 2.5% during the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock worth $2,867,514,000 after purchasing an additional 424,469 shares in the last quarter. Finally, Numeric Investors LLC boosted its position in CIGNA by 76.0% during the second quarter. Numeric Investors LLC now owns 714,702 shares of the health services provider’s stock worth $119,634,000 after purchasing an additional 308,702 shares in the last quarter. 87.74% of the stock is currently owned by hedge funds and other institutional investors.

In other news, CAO Mary T. Hoeltzel sold 575 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $197.03, for a total value of $113,292.25. Following the transaction, the chief accounting officer now owns 2,499 shares in the company, valued at $492,377.97. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Chairman Isaiah Harris, Jr. sold 212 shares of the firm’s stock in a transaction that occurred on Monday, December 11th. The shares were sold at an average price of $209.35, for a total value of $44,382.20. The disclosure for this sale can be found here. In the last 90 days, insiders sold 34,936 shares of company stock worth $6,979,204. Company insiders own 1.30% of the company’s stock.

CIGNA Co. (CI) traded up $3.80 during midday trading on Friday, hitting $210.89. The stock had a trading volume of 1,196,800 shares, compared to its average volume of 1,105,450. The stock has a market capitalization of $52,530.00, a P/E ratio of 23.10, a PEG ratio of 1.44 and a beta of 0.51. CIGNA Co. has a 1-year low of $133.52 and a 1-year high of $212.46. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.39 and a current ratio of 0.39.

CIGNA (NYSE:CI) last released its earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, beating the consensus estimate of $2.36 by $0.47. The business had revenue of $10.38 billion for the quarter, compared to the consensus estimate of $10.17 billion. CIGNA had a return on equity of 18.85% and a net margin of 5.74%. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.94 earnings per share. research analysts forecast that CIGNA Co. will post 10.34 EPS for the current fiscal year.

A number of equities analysts have issued reports on the company. ValuEngine upgraded CIGNA from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Goldman Sachs Group assumed coverage on CIGNA in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $247.00 price target on the stock. BMO Capital Markets assumed coverage on CIGNA in a research report on Monday, October 16th. They set a “market perform” rating and a $210.00 price target on the stock. Morgan Stanley increased their price target on CIGNA from $195.00 to $223.00 and gave the stock an “overweight” rating in a research report on Friday, November 3rd. Finally, Citigroup increased their price target on CIGNA from $198.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Three equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $205.18.

TRADEMARK VIOLATION WARNING: “Nisa Investment Advisors LLC Has $22.52 Million Position in CIGNA Co. (CI)” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2018/01/12/nisa-investment-advisors-llc-has-22-52-million-position-in-cigna-co-ci.html.

CIGNA Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Stock Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related stocks with our FREE daily email newsletter.